Omega-3 fatty acid ethyl esters (Omacor^®) for the treatment of hypertriglyceridemia

By Bhatnagar Deepak   Hussain Fatima  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 263-270

Future Medicine

Access to resources Recommend Favorite

Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids

By Brunton Stephen   Collins Nancy  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1139-1145

Informa Healthcare

Access to resources Recommend Favorite

Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients

By Bays Harold E.   Maki Kevin C.   McKenney James   Snipes Rose   Meadowcroft Amy   Schroyer Rosemary   Doyle Ralph T.   Stein Evan  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 907-915

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega-3 polyunsaturated fatty acid ethyl esters

By Halcox Julian P  

Clinical Lipidology, Vol. 8, Iss. 3, 2013-06 ,pp. : 329-344

Future Medicine

Access to resources Recommend Favorite

Early Impact of Prescription Omega-3 Fatty Acids on Platelet Biomarkers in Patients with Coronary Artery Disease and Hypertriglyceridemia

By  

Cardiology, Vol. 118, Iss. 3, 2011-06 ,pp. : 187-194

Karger

Access to resources Recommend Favorite